PTCH1 and medulloblastoma: We chose to work with cells derived from the GFAPcre mediated Ptch1 conditional mutant mouse (Ptch1lox/lox;GFAPcre), which develop medulloblastoma with 100% incidence by four weeks of age [13, 33–35].